IUBio

Nootropics

Pinky pinky at primenet.com
Tue Feb 14 19:52:33 EST 1995


Ronald B. Keys J.D. Ph.D (rkeysphd at pipeline.com) wrote:
: Dear Pinky,  
:  
: Clinicians who incorporate functional, complimentary medicine into their
: practice are very familiar with these products.  I am not a physician.
: However, as a  clinician counseling professional I am familiar with them
: and in appropriate cases, may recommend their use. Its part of patient
: education and empowerment.  Some of them, when used appropriately  by
: charting a  dose-response curve with a patient, may  enhance normal
: function. Recent MRI and brain regional blood flow studies support uses of
: gingko biloba.  See uses of gingko in relieving depression and other
: symptoms in; Lesser, IM, et al. Reduction of cerebral Blood Flow in older
: depressed patients.  Arch Gen Psychiatry  1994;51:677-686. Anybody using
: these agents should be heavily databased first, and then under responsible
: supervision to avoid the downside of a dose-response curve. Everything in
: this world is double edged. 
:  
: The Townsend Letter For Doctors, a monthly magazine, covers research in
: this area of holistic medicine.  You can also join a new database called
: the Alternative Medicine Connection by calling Arlene Brecher at (703)
: 471-4734 to order a free dial up disk. This can keep you current on these
: products. 
:  
:  
: From the cutting edge,  
:  
:  
: Ronald B. Keys, JD, PhD (rkeysphd at pipeline.com) (2-12-95) 
: Queens, NYC (718) 460-3966  American Academy of Anti-Aging Medicine,
: American Academy of Clinical Gerontology, American Aging Association,
: National Academy of Elder Law Attorneys, International Association of
: Biomedical Gerontology, Life Extension Foundation


Thanks for your reply to my posting concerning nootropic agents.
I've been taking Gingko now for about 2 months based on a review
in Lancet and medline research I did.  It seems there is some improvment 
in memory, but nothing substancial. I read a few reports from individuals
taking a compination of Piracetum, Hydergine and Gingko at reduced 
dosages, which were favorable. It seems to me that with the computer
sophistication we have available that cross-referencing PET scans; other
diagnostic tools with these drugs would yield concrete results?



More information about the Neur-sci mailing list

Send comments to us at biosci-help [At] net.bio.net